Amloz 2.5MG
RALLIS INDIA LTD` - 2.5 mg - 30 S
Standard delivery
Distributor inventory
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Hyaluronidase Injection IP 1500 IU/2 mL (1500 IU vial with 2 mL diluent)
Adjunct to increase dispersion and absorption of injected drugs and fluids (hypodermoclysis), to facilitate subcutaneous/IM injections, and to promote reabsorption of excess fluids (e.g., edema, hematoma); also used as an adjunct in local anaesthesia (e.g., ophthalmic procedures) as per clinician.
Hyaluronidase is an enzyme that depolymerizes hyaluronic acid in connective tissue. This temporarily decreases the viscosity of the intercellular matrix and increases tissue permeability, enhancing spread and absorption of injected solutions.
For injection use only, administered by a healthcare professional. Given subcutaneously, intramuscularly, or locally mixed with/alongside compatible solutions as advised. Dose and technique depend on the procedure and clinical indication; follow physician instructions and do not self-administer.
Common side effects of Hynidase 2ML may include:
RALLIS INDIA LTD` - 2.5 mg - 30 S
Standard delivery

RALLIS INDIA LTD` - 5 mg - 30 S
Standard delivery
RALLIS INDIA LTD` - 14 S
Standard delivery
RALLIS INDIA LTD` - 14 S
Standard delivery
RALLIS INDIA LTD` - tablet - 15 S
Standard delivery

RALLIS INDIA LTD` - 100 ml
Standard delivery

RALLIS INDIA LTD` - tablet - 10 S
Standard delivery
RALLIS INDIA LTD` - 30 S
Standard delivery
Prescription-only; use only under medical supervision. Do not use in patients with known hypersensitivity to hyaluronidase or components. Use caution in areas of infection, inflammation, or malignancy (may increase spread). Not for intravenous use. Avoid use to enhance absorption of local anaesthetics in areas supplied by end arteries (risk of ischemia). Monitor for allergic reactions; keep emergency treatment available.